Liquidia Corporation

NasdaqCM LQDA

Liquidia Corporation Share Price on January 14, 2025: USD 11.36

Liquidia Corporation Share Price is USD 11.36 on January 14, 2025, a -8.24% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Liquidia Corporation 52-week high Share Price is USD 16.73 on March 22, 2024, which is 47.27% above the current Share Price.
Liquidia Corporation 52-week low Share Price is USD 8.90 on September 10, 2024, which is -21.65% below the current Share Price.
Liquidia Corporation average Share Price for the last 52 weeks is USD 12.22.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqCM: LQDA

Liquidia Corporation

CEO	Dr. Roger A. Jeffs Ph.D.
IPO Date	July 26, 2018
Location	United States
Headquarters	419 Davis Drive
Employees	145
Sector	Health Care
Industries Pharmaceuticals

Description

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Key trends

Past 5 years